Dr. Ana De Jesus-Acosta, MD
Claim this profileMore about Ana De Jesus-Acosta, MD
Clinical Trial Related
9 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical Trials
Treatments Ana De Jesus-Acosta, MD has experience with
- BMS-986253
- Cyclophosphamide
- GVAX Pancreatic Cancer
- Nivolumab
- Urelumab
Breakdown of trials Ana De Jesus-Acosta, MD has run
Pancreatic Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ana De Jesus-Acosta, MD specialize in?
Ana De Jesus-Acosta, MD focuses on Pancreatic Cancer and other conditions. In particular, much of their work with Pancreatic Cancer has involved treating patients, or patients who are undergoing treatment.
Is Ana De Jesus-Acosta, MD currently recruiting for clinical trials?
No, Ana De Jesus-Acosta, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Ana De Jesus-Acosta, MD has studied deeply?
Yes, Ana De Jesus-Acosta, MD has studied treatments such as BMS-986253, Cyclophosphamide, GVAX pancreatic cancer.
What is the best way to schedule an appointment with Ana De Jesus-Acosta, MD?
Apply for one of the trials that Ana De Jesus-Acosta, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.